NCT07803874 UV-Trichoscopic Red Fluorescence in Alopecia Areata
| NCT ID | NCT07803874 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Training and Research Hospital |
| Condition | Alopecia Areata |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-07-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn whether red fluorescence seen with ultraviolet (UV) trichoscopy is related to disease findings and treatment response in adults with limited plaque-type alopecia areata. Trichoscopy is a close-up imaging method used to examine the hair and scalp. The study will investigate whether the amount of red fluorescence at the beginning of the study is related to how soon hair starts to grow back, how much hair regrows, and how trichoscopic findings change during follow-up. Participants for whom intralesional corticosteroid treatment has been planned as part of their regular medical care will have standard trichoscopic and UV-trichoscopic images taken of the affected scalp area. They will be followed at weeks 4, 8, and 12, when hair regrowth and changes in scalp and hair findings will be evaluated. Researchers will measure red fluorescence in the images and examine whether it is related to treatment response over time.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Limited plaque-type alopecia areata of the scalp * Active hair loss * Symptom onset within the previous 6 months * No topical, intramuscular, or oral treatment for alopecia areata within the previous 1 month * No intralesional corticosteroid treatment within the previous 6 weeks * Provision of informed consent Exclusion Criteria: * Beard alopecia areata * Very extensive alopecia areata or multiple large plaques * Tinea capitis or active infection * Current phototherapy * Systemic immunosuppressive treatment within the washout period specified in the study protocol * Pregnancy or breastfeeding * Contraindication to UV imaging
Contact & Investigator
Vildan Manav
STUDY CHAIR
Istanbul Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07803874 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alopecia Areata. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07803874 currently recruiting?
Yes, NCT07803874 is actively recruiting participants. Contact the research team at snapucu@gmail.com for enrollment information.
Where is the NCT07803874 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07803874 clinical trial?
NCT07803874 is sponsored by Istanbul Training and Research Hospital. The principal investigator is Vildan Manav at Istanbul Training and Research Hospital. The trial plans to enroll 40 participants.